How Much Does Tesamorelin Therapy Cost?

Cost Overview

Tesamorelin is one of the few peptides with direct FDA approval (under the brand name Egrifta), which influences its pricing in complex ways. The branded version can be very expensive, while compounded formulations are more accessible. As a growth hormone releasing hormone analog, Tesamorelin is specifically researched for its effects on visceral fat and body composition. Its FDA-approved status gives it a unique position in the peptide market, and some patients may have insurance pathways for the branded version under specific diagnoses.

Factors That Affect Tesamorelin Pricing

• •Branded (Egrifta) vs. compounded formulation: dramatic price difference
• •Insurance coverage potential for branded version with qualifying diagnosis
• •Daily injection requirement affects monthly peptide supply consumption
• •Protocol duration: typically 6+ months for body composition goals
• •Provider experience with growth hormone peptide therapy

What's Usually Included

• ✓Growth hormone and body composition consultation
• ✓Tesamorelin supply for prescribed duration
• ✓Self-injection training and supplies
• ✓Periodic body composition and lab monitoring
• ✓Protocol management and dosage optimization

Insurance & Coverage

The branded version (Egrifta) has FDA approval for HIV-associated lipodystrophy and may be covered by insurance for this specific indication. For off-label use, insurance coverage is unlikely. Compounded Tesamorelin is not covered. Manufacturer patient assistance programs may be available for the branded version.

Tips for Finding Affordable Tesamorelin Providers

Compounded Tesamorelin is typically 50-75% less expensive than the branded Egrifta product. For patients seeking growth hormone peptide therapy on a budget, Sermorelin and Ipamorelin are less expensive alternatives with similar goals. Multi-month supply commitments often come with volume discounts from compounding pharmacies.

Related Pages